ABSTRACT
Clinical guidelines for treating ITP are based on the consensus of an expert panel, as randomized trials are lacking. Newer genetically engineered treatments hold promise but await definitive study.
- Copyright © 1998 The Cleveland Clinic Foundation. All Rights Reserved.
Log in using your username and password
Registration is Now Required for Free Access to CCJM Content
Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.
If you are using a mobile device, click on the settings icon to access the Register link.
Idiopathic thrombocytopenic purpura: Guidance amid uncertainty
Jump to section
Related Articles
Cited By...
- No citing articles found.